Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM serves as Associate Professor of Emergency Medicine and the Director of Addiction-Toxicology and the Toxicology/Addiction Consult Service at Strong Memorial Hospital and the University of Rochester Medical Center. Dr.Wiegand started treating addiction nearly 20 years ago and has since worked to bridge the fields of addiction medicine and medical toxicology. In addition to emergency department, hospital, and clinic work treating drug exposures, intoxication, and withdrawal, and assisting with pain management for patients maintained on Medications for Opioid Use Disorder in the emergency department, hospital, and perioperative setting, Dr. Wiegand is also involved with medical education and research in toxicology and addiction.

Dr. Wiegand is the Program Director for the UR Emergency Medicine & Toxicology-based Addiction Medicine Fellowship Program, and he is core faculty for the Emergency Medicine residency at Strong Memorial Hospital. He lectures locally, regionally, nationally, and internationally on topics in addiction medicine and medical toxicology. Dr. Wiegand currently serves on the ASAM Board of Directors as Vice President and has served two terms as a board member of the American College of Medical Toxicology. He has also been Treasurer and Finance Chair for the Medical Toxicology Foundation and he is a Past President of the New York Society of Addiction Medicine.

Prior to serving as Vice President of ASAM, Dr. Wiegand was an At-Large Board Director for ASAM. He has also served on the nominations committee and participated in numerous other groups including expert panels, in the development of educational content, and in the creation of Position Statements and Guidelines (e.g., Drug Testing in Clinical Addiction Medicine and the Stimulant Use Disorder Guidance documents).

Dr. Wiegand regularly presents at the ASAM Annual Conference, through lectures and workshops, as well as presenting posters and mentoring young investigators. In addition to the annual conference Dr. Wiegand has presented at the Board Review Course and for live webinars and the eLearning platform on educational content related to pain and OUD, drug testing, and other topics. He also leads and moderates the monthly Addiction Toxicology Case Conference featuring live interactive discussion with expert panelists on cases that fall into the intersection of Addiction Medicine and Medical Toxicology.

Dr. Wiegand served as President of NYSAM during the COVID19 pandemic and helped guide the NYSAM chapter into its first virtual annual conference and public policy day. NYSAM has since expanded virtual education into other activities including a Cannabis Webinar series which he developed and curates content for. He also led the transition to new administrative support through the New York state Medical Society and he oversaw a Bylaws review and update which expanded the NYSAM Board, adding a trainee board position (student, resident or fellow), among other updates.

Dr. Wiegand actively mentors ASAM members. His fellows and mentees have gone on to take leadership positions within NYSAM and ASAM and in their community or institutions. In recognition of his service and leadership at the 2022 ASAM Annual Conference Dr. Wiegand was awarded the ASAM Annual Award which recognizes and honors an individual for outstanding contributions to the growth and vitality of ASAM, for thoughtful leadership in the field, and for deep understanding of the art and science of addiction medicine, as well as for expanding the frontiers of the field of addiction medicine and broadening our understanding of the addictive process through research and innovation.

Disclosure of Interests and Affiliations